🇺🇸 CHLORTETRACYCLINE HYDROCHLORIDE in United States

24 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Dyskinesia — 4 reports (16.67%)
  2. Therapy Change — 4 reports (16.67%)
  3. Acute Kidney Injury — 2 reports (8.33%)
  4. Anaemia — 2 reports (8.33%)
  5. Chronic Kidney Disease — 2 reports (8.33%)
  6. Condition Aggravated — 2 reports (8.33%)
  7. Decreased Appetite — 2 reports (8.33%)
  8. Dizziness — 2 reports (8.33%)
  9. Hepatic Function Abnormal — 2 reports (8.33%)
  10. Pancreatitis — 2 reports (8.33%)

Source database →

CHLORTETRACYCLINE HYDROCHLORIDE in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Infectious Disease approved in United States

Frequently asked questions

Is CHLORTETRACYCLINE HYDROCHLORIDE approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for CHLORTETRACYCLINE HYDROCHLORIDE in United States?

Marketing authorisation holder not available in our data.